The possibility of regulating individual gene activities in the mouse brain
via the tetracycline-controlled transcriptional activation systems has spa
rked the development of novel mouse models aimed at elucidating the molecul
ar mechanisms of brain disorders such as Huntington's, prion and Parkinson'
s diseases. In the past year, novel experimental strategies and methodologi
cal advances have emerged, contributing to the resolution of some of the in
itial limitations of these regulatory systems.